Showing results (91-100 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|September 3, 2016
Characterizing monoclonal antibody formulations in arginine glutamate solutions using 1H NMR spectroscopyPriscilla Kheddo, Matthew J Cliff, Shahid Uddin, et al.Mabs|September 10, 2016
Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodiesTetyana Dashivets, Jan Stracke, Stefan Dengl, et al.Mabs|June 6, 2017
Enhanced immunization techniques to obtain highly specific monoclonal antibodiesRodrigo de Almeida, Cecília Naomi Nakamura, Marina de Lima Fontes, et al.Mabs|June 6, 2017
Impact of S-sulfocysteine on fragments and trisulfide bond linkages in monoclonal antibodiesRonja Seibel, Sandra Maier, Alisa Schnellbaecher, et al.Mabs|June 8, 2017
Evidence for intermolecular domain exchange in the Fab domains of dimer and oligomers of an IgG1 monoclonal antibodyYin Luo, Stephen W Raso, Judith Gallant, et al.Mabs|March 2, 2010
Catumaxomab: clinical development and future directionsRolf Linke, Anke Klein, Diane SeimetzMabs|June 16, 2017
Characterization of highly concentrated antibody solution - A toolbox for the description of protein long-term solution stabilityMarie-Therese Schermeyer, Anna K Wöll, Bas Kokke, et al.Mabs|May 6, 2017
Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal useFiona Sewell, Kathryn Chapman, Jessica Couch, et al.Mabs|April 11, 2018
Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approachAlison Betts, Anne Keunecke, Tamara J van Steeg, et al.Pageof 180